Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7103183 | 0.80 | ALDH1A1 (0.46) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL259453 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL10887539 | 0.77 | ALDH1A1 (0.43) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL9038846 | 0.77 | ALDH1A1 (0.67) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL8944374 | 0.77 | ALDH1A1 (0.43) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL8944049 | 0.74 | ACVRL1 (0.41) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL272835 | 0.73 | ALDH1A1 (0.67) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL4255764 | 0.73 | ALDH1A1 (0.56) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL5164814 | 0.72 | ALDH1A1 (0.65) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 | |
| SCHEMBL8421909 | 0.72 | ALDH1A1 (0.65) | ALDH1A1ENPP1KDM4EMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1251396-A2 | Methods for making photothermographic emulsions and materials | EASTMAN KODAK COMPANY (US) | 2002-10-23 | — | — | EP | claimed |
| US-6413710-B1 | USING ORGANONITROGEN RING COMPOUND | EASTMAN KODAK COMPANY | 2002-07-02 | — | — | US | claimed |
| US-4126472-A | Process of making a lithographic photosensitive silver halide emulsion having reduced susceptibility to pressure containing an iridium compound, a hydroxytetrazaindene and a polyoxyethylene | FUJI PHOTO FILM CO., LTD. (JP) | 1978-11-21 | — | — | US | claimed |
| US-4108662-A | Process for developing photographic light-sensitive materials for the graphic arts | FUJI PHOTO FILM CO., LTD. (JP) | 1978-08-22 | — | — | US | claimed |
| US-4078937-A | SULFUR, HYDROXYTETRAAZAINDENE | FUJI PHOTO FILM CO., LTD. (JA) | 1978-03-14 | — | — | US | claimed |
| US-20170216295-A1 | CCR9 ANTAGONIST COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2017-08-03 | — | — | US | disclosed |
| US-20070236764-A1 | SILVER HALIDE HOLOGRAHIC SENSITIVE MATERIAL AND SYSTEM FOR TAKING HOLOGRAHIC IMAGES BY USING THE SAME | FUJIFILM CORPORATION | 2007-10-11 | — | — | US | disclosed |
| EP-1217432-B1 | Silver halide photographic light-sensitive material and method for processing the same | FUJIFILM CORP (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-7241564-B2 | Silver halide holographic sensitive material and system for taking holographic images by using the same | FUJIFILM CORPORATION (JP) | 2007-07-10 | — | — | US | disclosed |
| EP-1798608-A1 | Hologram production method and hologram production system employing silver halide photosensitive material | Fujifilm Corporation (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20070134559-A1 | Hologram production method and hologram production system employing silver halide photosensitive material | FUJIFILM CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
| EP-1691237-A2 | Holographic recording material and holographic recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2006-08-16 | — | — | EP | disclosed |
| EP-0122125-A1 | Silver halide emulsion | KONICA CORPORATION (JP) | 1984-10-17 | — | — | EP | disclosed |
| EP-0121435-A1 | Silver halide photographic materials | KONICA CORPORATION (JP) | 1984-10-10 | — | — | EP | disclosed |
| EP-0107488-A2 | Silver halide emulsions | KONICA CORPORATION (JP) | 1984-05-02 | — | — | EP | disclosed |
| EP-0091788-A2 | Silver halide photographic material | KONICA CORPORATION (JP) | 1983-10-19 | — | — | EP | disclosed |
| EP-0089101-A2 | Direct positive image-forming process | KONICA CORPORATION (JP) | 1983-09-21 | — | — | EP | disclosed |
| US-4126472-A | Process of making a lithographic photosensitive silver halide emulsion having reduced susceptibility to pressure containing an iridium compound, a hydroxytetrazaindene and a polyoxyethylene | FUJI PHOTO FILM CO., LTD. (JP) | 1978-11-21 | — | — | US | disclosed |
| US-4108662-A | Process for developing photographic light-sensitive materials for the graphic arts | FUJI PHOTO FILM CO., LTD. (JP) | 1978-08-22 | — | — | US | disclosed |
| US-3977880-A | Direct-positive emulsion containing silver halide grains internally doped with metal ions, surface ripened with gold and sulfur compound and fogged by light exposure | FUJI PHOTO FILM CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216295-A1 | CCR9 ANTAGONIST COMPOUNDS | CCR9, CCR1, CCR10 | ALDH1A1 1264/4885ENPP1 1752/4885KDM4E 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.